JOGC

Managing Menopause Chapter 9 Complementary and Alternative Medicine (CAM)

        Women between 45 and 64 years old are significant users of CAM, including natural products.
        • Lunny C.A.
        • Fraser S.N.
        The use of complementary and alternative medicines among a sample of Canadian menopausal-aged women.
        The US National Center for Complementary and Alternative Medicine
        (NCCAM) has defined CAM as “a group of diverse medical and health care systems, practices, and products that are not generally considered to be part of conventional medicine”. NCCAM classifies CAM into 5 main groups: alternative medical systems, mind-body interventions, biologically based therapies including NHPs, manipulative and body-based methods, and energy therapies.
        To read this article in full you will need to make a payment

        REFERENCES

          • Lunny C.A.
          • Fraser S.N.
          The use of complementary and alternative medicines among a sample of Canadian menopausal-aged women.
          J Midwifery Womens Health. 2010; 55: 335-343
        1. Complementary, alternative, or integrative health: What’s in a name? NCCAM, Bethasda, Maryland2008 (Available at:) (Accessed 2013 Jan 31)
          • Kupferer E.M.
          • Dormire S.L.
          • Becker H.
          Complementary and alternative medicine use for vasomotor symptoms among women who have discontinued hormone therapy.
          J Obstet Gynecol Neonatal Nurs. 2009; 38: 50-59
          • Gold E.B.
          • Bair Y.
          • Zhang G.
          • Utts J.
          • Greendale G.A.
          • Upchurch D.
          • et al.
          Cross-sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women’s Health Across the Nation (SWAN).
          Menopause. 2007; 14: 612-623
          • Lin J.S.
          • O’Connor E.
          • Whitlock E.P.
          • Beil T.L.
          • Zuber S.P.
          • Perdue L.A.
          • et al.
          Behavioral counseling to promote physical activity and a healthful diet to prevent cardiovascular disease in adults: update of the evidence for the U.S. Preventive Services Task Force. Evidence Synthesis no. 79. AHRQ publication no. 11–05149-EF-1. US Agency for Healthcare Research and Quality, Rockville, Maryland2010: 24-26
          • Rees M.
          • Stevenson J.
          Primary prevention of coronary heart disease in women.
          Menopause Int. 2008; 14: 40-45
          • Stehr M.D.
          • von Lengerke T.
          Preventing weight gain through exercise and physical activity in the elderly: a systematic review.
          Maturitas. 2012; 72: 13-22
          • Martyn-St James M.
          • Carroll S.
          Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.
          Bone. 2008; 43: 521-531
          • Herber-Gast G.C.
          • Mishra G.D.
          • van der Schouw Y.T.
          • Brown W.J.
          • Dobson A.J.
          Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study.
          Menopause. 2013; 20: 953-959
          • Sternfeld B.
          • Dugan S.
          Physical activity and health during the menopausal transition.
          Obstet Gynecol Clin North Am. 2011; 38: 537-566
          • Pilsakova L.
          • Riecansky I.
          • Jagla F.
          The physiological actions of isoflavone phytoestrogens.
          Physiol Res. 2010; 59: 651-664
          • Eden J.A.
          Phytoestrogens for menopausal symptoms: a review.
          Maturitas. 2012; 72: 157-159
          • Jacobs A.
          • Wegewitz U.
          • Sommerfeld C.
          • Grossklaus R.
          • Lampen A.
          Efficacy of isoflavones in relieving vasomotor menopausal symptoms: a systematic review.
          Mol Nutr Food Res. 2009; 53: 1084-1097
          • Tempfer C.B.
          • Bentz E.K.
          • Leodolter S.
          • Tscherne G.
          • Reuss F.
          • Cross H.S.
          • et al.
          Phytoestrogens in clinical practice: a review of the literature.
          Fertil Steril. 2007; 87 (Epub 2007 May 9): 1243-1249
        2. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
          Menopause. 2011; 18: 732-753
          • Baber R.J.
          • Templeman C.
          • Morton T.
          • Kelly G.E.
          • West L.
          Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women.
          Climacteric. 1999; 2: 85-92
          • Coon J.T.
          • Pittler M.H.
          • Ernst E.
          Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis.
          Phytomedicine. 2007; 14 (Epub 2007 Jan 18): 153-159
          • Jeri A.R.
          The use of an isoflavone supplement to relieve hot flushes.
          Female Patient. 2002; 27: 35-37
          • Nachtigall L.B.
          • Fenichel R.
          • La Grega L.
          • Lee W.W.
          • Nachtigall L.
          The effects of isoflavone derived from red clover on vasomotor symptoms, endometrial thickness, and reproductive hormone concentrations in menopausal women [abstr].
          in: Presented at 81st Annual Meeting of the Endocrine Society, June 12–151999 (San Diego, California)
          • Knight D.C.
          • Howes J.B.
          • Eden J.A.
          The effect of Promensil, an isoflavone extract, on menopausal symptoms.
          Climacteric. 1999; 2: 79-84
          • van de Weijer P.H.
          • Barentsen R.
          Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.
          Maturitas. 2002; 42: 187-193
          • Lipovac M.
          • Chedraui P.
          • Gruenhut C.
          • Gocan A.
          • Kurz C.
          • Neuber B.
          • et al.
          The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women.
          Gynecol Endocrinol. 2012; 28 (Epub 2011 Aug 26): 203-207
          • Tice J.A.
          • Ettinger B.
          • Ensrud K.
          • Wallace R.
          • Blackwell T.
          • Cummings S.R.
          Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
          JAMA. 2003; 290: 207-214
          • Dodin S.
          • Lemay A.
          • Jacques H.
          • Legare F.
          • Forest J.C.
          • Masse B.
          The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial.
          J Clin Endocrinol Metab. 2005; 90: 1390-1397
          • Lewis J.E.
          • Nickell L.A.
          • Thompson L.U.
          • Szalai J.P.
          • Kiss A.
          • Hilditch J.R.
          A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause.
          Menopause. 2006; 13: 631-642
          • Simbalista R.L.
          • Sauerbronn A.V.
          • Aldrighi J.M.
          • Areas J.A.
          Consumption of a flaxseed-rich food is not more effective than a placebo in alleviating the climacteric symptoms of postmenopausal women.
          J Nutr. 2010; 140: 293-297
          • Lucas E.A.
          • Wild R.D.
          • Hammond L.J.
          • Khalil D.A.
          • Juma S.
          • Daggy B.P.
          • et al.
          Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women.
          J Clin Endocrinol Metab. 2002; 87: 1527-1532
          • Ma D.F.
          • Qin L.Q.
          • Wang P.Y.
          • Katoh R.
          Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials.
          Clin Nutr. 2008; 27: 57-64
          • Coxam V.
          Phyto-oestrogens and bone health.
          Proc Nutr Soc. 2008; 67: 184-195
          • Levis S.
          • Strickman-Stein N.
          • Ganjei-Azar P.
          • Xu P.
          • Doerge D.R.
          • Krischer J.
          Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial.
          Arch Intern Med. 2011; 171: 1363-1369
          • Hooper L.
          • Kroon P.A.
          • Rimm E.B.
          • Cohn J.S.
          • Harvey I.
          • Le Cornu K.A.
          • et al.
          Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials.
          Am J Clin Nutr. 2008; 88: 38-50
          • Pan A.
          • Yu D.
          • Demark-Wahnefried W.
          • Franco O.H.
          • Lin X.
          Meta-analysis of the effects of flaxseed interventions on blood lipids.
          Am J Clin Nutr. 2009; 90: 288-297
          • Patisaul H.B.
          • Jefferson W.
          The pros and cons of phytoestrogens.
          Front Neuroendocrinol. 2010; 31 (Epub 2010 Mar 27): 400-419
          • Dong J.Y.
          • Qin L.Q.
          Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies.
          Breast Cancer Res Treat. 2011; 125: 315-323
          • Guha N.
          • Kwan M.L.
          • Quesenberry Jr., C.P.
          • Weltzien E.K.
          • Castillo A.L.
          • Caan B.J.
          Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.
          Breast Cancer Res Treat. 2009; 118: 395-405
          • Buck K.
          • Zaineddin A.K.
          • Vrieling A.
          • Linseisen J.
          • Chang-Claude J.
          Meta-analyses of lignans and enterolignans in relation to breast cancer risk.
          Am J Clin Nutr. 2010; 92: 141-153
          • Tempfer C.B.
          • Froese G.
          • Heinze G.
          • Bentz E.K.
          • Hefler L.A.
          • Huber J.C.
          Side effects of phytoestrogens: a meta-analysis of randomized trials.
          Am J Med. 2009; 122: 939-946
          • Foster S.
          Black cohosh: a literature review.
          HerbalGram. 1999; 45: 35-50
          • Beuscher N.
          Cimicifuga racemosa L.-Die Traubensilberkerze - Portrait einer Arzneipflanze. Z Phytother, 1995: 301-310
          • Leach M.J.
          • Moore V.
          Black cohosh (Cimicifuga spp.) for menopausal symptoms.
          Cochrane Database Syst Rev. 2012; 9: CD007244
          • Laakmann E.
          • Grajecki D.
          • Doege K.
          • zu Eulenburg C.
          • Buhling K.J.
          Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review.
          Gynecol Endocrinol. 2012; 28: 703-709
          • Naser B.
          • Schnitker J.
          • Minkin M.J.
          • de Arriba S.G.
          • Nolte K.U.
          • Osmers R.
          Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract.
          Menopause. 2011; 18: 366-375
          • Whiskey E.
          • Werneke U.
          • Taylor D.
          A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
          Int Clin Psychopharmacol. 2001; 16: 239-252
          • Linde K.
          • Mulrow C.
          • Berner M.
          • Egger M.
          St John’s Wort for depression.
          Cochrane Database Syst Rev. 2005; 2: CD000448
          • Roder C.
          • Schaefer M.
          • Leucht S.
          Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John’s wort.
          Fortschr Neurol Psychiatr. 2004; 72: 330-343
          • Al-Akoum M.
          • Maunsell E.
          • Verreault R.
          • Provencher L.
          • Otis H.
          • Dodin S.
          Effects of Hypericum perforatum (St. John’s wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
          Menopause. 2009; 16: 307-314
          • Schulz V.
          Safety of St. John’s wort extract compared to synthetic antidepressants.
          Phytomedicine. 2006; 13: 199-204
          • Wang C.C.
          • Cheng K.F.
          • Lo W.M.
          • Law C.
          • Li L.
          • Leung P.C.
          • et al.
          A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (dang gui buxue tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women.
          Menopause. 2013; 20: 223-231
          • Borrelli F.
          • Ernst E.
          Alternative and complementary therapies for the menopause.
          Maturitas. 2010; 66: 333-343
          • Nasir L.S.
          Acupuncture.
          Prim Care. 2002; 29: 393-405
          • Dodin S.
          • Blanchet C.
          • Marc I.
          • Ernst E.
          • Wu T.
          • Vaillancourt C.
          • et al.
          Acupuncture for menopausal hot flushes.
          Cochrane Database Syst Rev. 2013; 7: CD007410
          • Ernst E.
          • Lee M.S.
          • Choi T.Y.
          Acupuncture in obstetrics and gynecology: an overview of systematic reviews.
          Am J Chin Med. 2011; 39: 423-431
          • Wayne P.M.
          • Kiel D.P.
          • Krebs D.E.
          • Davis R.B.
          • Savetsky-German J.
          • Connelly M.
          • et al.
          The effects of tai chi on bone mineral density in postmenopausal women: a systematic review.
          Arch Phys Med Rehabil. 2007; 88: 673-680
          • Low S.
          • Ang L.W.
          • Goh K.S.
          • Chew S.K.
          A systematic review of the effectiveness of tai chi on fall reduction among the elderly.
          Arch Gerontol Geriatr. 2009; 48 (Epub 2008 Apr 16): 325-331
          • Daley A.J.
          • Stokes-Lampard H.J.
          • Macarthur C.
          Exercise to reduce vasomotor and other menopausal symptoms: a review.
          Maturitas. 2009; 63: 176-180